牛叉诊股

[{"date":"2025.04.03","stock":"0.95","trade":"0.81","ind":"-1.40"},{"date":"2025.04.02","stock":"-0.81","trade":"-0.63","ind":"0.09"},{"date":"2025.04.01","stock":"3.04","trade":"3.06","ind":"-0.01"},{"date":"2025.03.31","stock":"-2.43","trade":"-1.41","ind":"-0.97"},{"date":"2025.03.28","stock":"-1.20","trade":"-1.54","ind":"-0.57"},{"date":"2025.03.27","stock":"0.40","trade":"0.80","ind":"0.23"},{"date":"2025.03.26","stock":"1.77","trade":"0.14","ind":"-0.05"},{"date":"2025.03.25","stock":"-0.81","trade":"-0.71","ind":"-0.43"},{"date":"2025.03.24","stock":"-0.13","trade":"-1.04","ind":"0.07"},{"date":"2025.03.21","stock":"0.54","trade":"0.68","ind":"-1.76"},{"date":"2025.03.20","stock":"-0.27","trade":"0.38","ind":"-0.91"},{"date":"2025.03.19","stock":"0.14","trade":"-0.09","ind":"-0.32"},{"date":"2025.03.18","stock":"0.00","trade":"0.26","ind":"0.52"},{"date":"2025.03.17","stock":"-0.27","trade":"0.33","ind":"-0.19"},{"date":"2025.03.14","stock":"1.51","trade":"1.99","ind":"2.26"},{"date":"2025.03.13","stock":"0.55","trade":"-0.09","ind":"-0.99"},{"date":"2025.03.12","stock":"0.00","trade":"-0.12","ind":"-0.17"},{"date":"2025.03.11","stock":"-0.28","trade":"0.23","ind":"0.33"},{"date":"2025.03.10","stock":"1.11","trade":"0.96","ind":"-0.17"},{"date":"2025.03.07","stock":"-0.55","trade":"-0.33","ind":"-0.50"},{"date":"2025.03.06","stock":"1.12","trade":"0.33","ind":"1.77"}]

精华制药,深证成指,中药指数

压力支撑

该股压力位为7.38元，支撑位为7.29元。

[{"text":"\u538b\u529b\u4f4d","value":"7.38","date":1743609600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.29","date":1743609600,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.6资金面打败了39%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体无进出。

更新时间：04月04日 20:31

机构今日流向(万元)	1066.61	机构5日流向(万元)	-328.75
机构10日流向(万元)	-2288.79	机构20日流向(万元)	-5271.16

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少31172.93万股，其中基金净增仓3家，主力净减仓10家，暂未发现中长期投资价值。

截止2024-12-31，共25家主力机构（基金25家），持仓量总计1464.56万股，占流通A股1.81%
其中，基金持仓与2024-06-30相比：
增仓：11家，增持 449.41万股
减仓：8家，减持 56.64万股
新出现在主力名单中：6家，持有31.85万股
从主力名单中消失：16家，原持有31597.55万股

消息面诊股

诊断结果：5消息面打败了26%的股票今日有利好新闻的公司

近期该股消息很少，消息面信号较弱。

消息面得分最高的股票

消息列表

一般消息	分红转增	不分配不转增	2024-08-28
一般消息	股东大会	临时股东大会	2024-05-21
一般消息	重大事项	关联交易	2024-05-18
利好	分红转增	10派0.92元(含税)	2024-04-19
一般消息	重大事项	关联交易	2024-04-19

一年消息统计

	所有消息	重大消息	非重大消息
利好	1条	0条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：6.9行业面打败了92%的股票中药行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2025.04.03","price":"-1.40","value":"0.81"},{"date":"2025.04.02","price":"0.09","value":"-0.63"},{"date":"2025.04.01","price":"-0.01","value":"3.06"},{"date":"2025.03.31","price":"-0.97","value":"-1.41"},{"date":"2025.03.28","price":"-0.57","value":"-1.54"},{"date":"2025.03.27","price":"0.23","value":"0.80"},{"date":"2025.03.26","price":"-0.05","value":"0.14"},{"date":"2025.03.25","price":"-0.43","value":"-0.71"},{"date":"2025.03.24","price":"0.07","value":"-1.04"},{"date":"2025.03.21","price":"-1.76","value":"0.68"},{"date":"2025.03.20","price":"-0.91","value":"0.38"},{"date":"2025.03.19","price":"-0.32","value":"-0.09"},{"date":"2025.03.18","price":"0.52","value":"0.26"},{"date":"2025.03.17","price":"-0.19","value":"0.33"},{"date":"2025.03.14","price":"2.26","value":"1.99"},{"date":"2025.03.13","price":"-0.99","value":"-0.09"},{"date":"2025.03.12","price":"-0.17","value":"-0.12"},{"date":"2025.03.11","price":"0.33","value":"0.23"},{"date":"2025.03.10","price":"-0.17","value":"0.96"},{"date":"2025.03.07","price":"-0.50","value":"-0.33"},{"date":"2025.03.06","price":"1.77","value":"0.33"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	157.98%	0.99%	5.5分
2	康惠制药	23.71%	2.38%	4.5分
3	陇神戎发	20.66%	2.40%	4.7分
4	维康药业	19.19%	4.55%	4.1分
5	ST目药	17.70%	1.38%	6.3分
6	健民集团	14.20%	3.95%	5.9分
7	佐力药业	12.27%	-1.83%	5.6分
8	华森制药	11.90%	3.83%	6.2分
9	恩威医药	11.23%	7.06%	4.1分
10	东阿阿胶	11.21%	3.47%	5.8分
11	羚锐制药	10.84%	5.21%	5.9分
12	方盛制药	10.40%	1.80%	4.5分
13	马应龙	10.17%	4.86%	6.2分
14	ST百灵	9.82%	-4.49%	4.7分
15	上海凯宝	9.21%	0.91%	4.8分
16	莱茵生物	8.21%	-1.09%	5.4分
17	沃华医药	7.52%	-0.21%	4.7分
18	华润三九	7.03%	4.18%	6.3分
19	新光药业	6.12%	0.49%	4.2分
20	益盛药业	5.94%	0.97%	4.9分
21	江中药业	5.92%	0.92%	5.9分
22	天士力	5.26%	4.21%	6.0分
23	桂林三金	5.14%	0.42%	5.8分
24	众生药业	5.07%	4.13%	5.4分
25	盘龙药业	4.62%	-1.19%	4.4分
26	康恩贝	4.55%	1.10%	5.5分
27	-	4.39%	4.39%	分
28	太龙药业	4.14%	2.40%	5.2分
29	红日药业	4.02%	1.69%	3.9分
30	亚宝药业	3.96%	0.80%	5.8分
31	汉森制药	3.92%	0.32%	5.3分
32	广誉远	3.80%	0.61%	5.3分
33	中恒集团	3.77%	-0.40%	4.7分
34	华神科技	3.73%	1.04%	4.8分
35	达仁堂	3.59%	-3.59%	4.5分
36	贵州三力	3.53%	-0.68%	5.0分
37	珍宝岛	3.20%	0.36%	5.6分
38	精华制药	3.18%	-0.53%	5.0分
39	云南白药	3.04%	1.42%	6.5分
40	千金药业	2.36%	-0.10%	5.0分
41	步长制药	2.33%	0.46%	5.1分
42	济川药业	2.32%	-0.64%	4.5分
43	奇正藏药	2.29%	-0.35%	5.4分
44	寿仙谷	2.18%	0.15%	4.5分
45	仁和药业	1.81%	0.36%	5.0分
46	葵花药业	1.46%	-0.71%	3.6分
47	同仁堂	1.40%	-0.54%	5.2分
48	昆药集团	1.27%	2.21%	5.8分
49	吉林敖东	1.14%	0.96%	5.1分
50	特一药业	1.12%	0.62%	3.4分
51	ST九芝	1.09%	-1.65%	4.6分
52	以岭药业	1.06%	-0.70%	4.2分
53	白云山	0.98%	-0.04%	5.6分
54	粤万年青	0.93%	1.37%	3.9分
55	片仔癀	0.60%	-1.65%	4.5分
56	益佰制药	0.28%	-1.11%	3.9分
57	太极集团	0.00%	6.08%	5.4分
58	金花股份	-1.40%	-1.03%	4.9分
59	康美药业	-1.40%	-1.86%	3.9分
60	嘉应制药	-1.92%	-3.77%	3.9分
61	启迪药业	-2.41%	3.85%	4.1分
62	康缘药业	-3.55%	-5.07%	4.1分
63	新天药业	-3.66%	-3.17%	3.9分
64	信邦制药	-4.28%	-0.78%	3.4分
65	*ST龙津	-5.48%	-4.83%	3.4分
66	葫芦娃	-6.23%	-1.12%	3.7分
67	长药控股	-7.59%	-10.22%	3.2分
68	*ST吉药	-14.15%	-5.21%	3.9分
69	-	-21.92%	-3.26%	分
70	ST香雪	-36.63%	-4.90%	3.5分
71	佛慈制药	-	1.25%	5.2分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：5.2基本面打败了22%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，暂时未获得多数机构的显著认同，后续可继续关注。

个股深一度

潜在高分红能力：弱（55分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 28/115 ， 40/115。

[{"date":"2024-09-30","value":"6.60","vol":"3.13"},{"date":"2024-06-30","value":"5.47","vol":"1.58"},{"date":"2024-03-31","value":"2.87","vol":"1.61"},{"date":"2023-12-31","value":"10.22","vol":"1.42"},{"date":"2023-09-30","value":"7.92","vol":"-36.50"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	6.60	5.47	2.87	10.22	7.92
行业(%)	3.13	1.58	1.61	1.42	-36.50

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"49.87","vol":"52.90"},{"date":"2024-06-30","value":"50.85","vol":"53.13"},{"date":"2024-03-31","value":"50.76","vol":"53.51"},{"date":"2023-12-31","value":"48.69","vol":"53.84"},{"date":"2023-09-30","value":"48.63","vol":"54.69"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	49.87	50.85	50.76	48.69	48.63
行业(%)	52.90	53.13	53.51	53.84	54.69

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 39/115 ， 35/115。

[{"date":"2024-09-30","value":"-6.65","vol":"-4.45"},{"date":"2024-06-30","value":"-9.43","vol":"-4.14"},{"date":"2024-03-31","value":"-11.82","vol":"-1.91"},{"date":"2023-12-31","value":"-3.90","vol":"4.46"},{"date":"2023-09-30","value":"-4.71","vol":"7.10"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	-6.65	-9.43	-11.82	-3.90	-4.71
行业(%)	-4.45	-4.14	-1.91	4.46	7.10

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"-15.93","vol":"-1.99"},{"date":"2024-06-30","value":"-12.40","vol":"-14.01"},{"date":"2024-03-31","value":"-18.92","vol":"-9.91"},{"date":"2023-12-31","value":"16.71","vol":"-18.86"},{"date":"2023-09-30","value":"15.68","vol":"9.87"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	-15.93	-12.40	-18.92	16.71	15.68
行业(%)	-1.99	-14.01	-9.91	-18.86	9.87

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 39/115 ， 26/115。

[{"date":"2024-09-30","value":"0.33","vol":"0.37"},{"date":"2024-06-30","value":"0.23","vol":"0.25"},{"date":"2024-03-31","value":"0.11","vol":"0.13"},{"date":"2023-12-31","value":"0.49","vol":"0.53"},{"date":"2023-09-30","value":"0.36","vol":"0.40"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	0.33	0.23	0.11	0.49	0.36
行业(次)	0.37	0.25	0.13	0.53	0.40

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.79","vol":"1.79"},{"date":"2024-06-30","value":"1.21","vol":"1.23"},{"date":"2024-03-31","value":"0.61","vol":"0.65"},{"date":"2023-12-31","value":"2.59","vol":"2.86"},{"date":"2023-09-30","value":"1.88","vol":"2.05"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	1.79	1.21	0.61	2.59	1.88
行业(次)	1.79	1.23	0.65	2.86	2.05

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"26.48","vol":"6.20"},{"date":"2024-06-30","value":"18.66","vol":"8.58"},{"date":"2024-03-31","value":"8.42","vol":"1.15"},{"date":"2023-12-31","value":"24.32","vol":"19.48"},{"date":"2023-09-30","value":"29.66","vol":"9.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	26.48	18.66	8.42	24.32	29.66
行业	6.20	8.58	1.15	19.48	9.00

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.59","vol":"1.35"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.33","vol":"1.45"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	0.59	-	0.33	-
行业	0.00	1.35	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 64/115 ， 65/115。

[{"date":"2024-09-30","value":"6.77","vol":"3.22"},{"date":"2024-06-30","value":"6.69","vol":"2.94"},{"date":"2024-03-31","value":"6.64","vol":"2.96"},{"date":"2023-12-31","value":"5.49","vol":"2.81"},{"date":"2023-09-30","value":"5.37","vol":"2.93"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	6.77	6.69	6.64	5.49	5.37
行业	3.22	2.94	2.96	2.81	2.93

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"5.77","vol":"2.43"},{"date":"2024-06-30","value":"5.51","vol":"2.23"},{"date":"2024-03-31","value":"5.43","vol":"2.28"},{"date":"2023-12-31","value":"4.50","vol":"2.14"},{"date":"2023-09-30","value":"4.45","vol":"2.21"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	5.77	5.51	5.43	4.50	4.45
行业	2.43	2.23	2.28	2.14	2.21

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 65/115 ， 63/115。

[{"date":"2024-09-30","value":"10.06","vol":"34.67"},{"date":"2024-06-30","value":"10.03","vol":"35.43"},{"date":"2024-03-31","value":"10.15","vol":"34.64"},{"date":"2023-12-31","value":"11.95","vol":"34.85"},{"date":"2023-09-30","value":"11.82","vol":"34.37"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	10.06	10.03	10.15	11.95	11.82
行业(%)	34.67	35.43	34.64	34.85	34.37

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"0.13","vol":"3.11"},{"date":"2024-06-30","value":"0.13","vol":"1.60"},{"date":"2024-03-31","value":"0.13","vol":"0.96"},{"date":"2023-12-31","value":"0.16","vol":"0.87"},{"date":"2023-09-30","value":"0.15","vol":"0.60"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	0.13	0.13	0.13	0.16	0.15
行业(%)	3.11	1.60	0.96	0.87	0.60

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2024年的收益，请投资者后续关注。

[{"date":"2020","yellowRectValue":"1.11","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"1.61","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.12","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.48","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[精华制药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]